Intercept Pharmaceuticals... (ICPT)
NASDAQ: ICPT
· Real-Time Price · USD
19.00
0.04 (0.21%)
At close: Nov 07, 2023, 10:00 PM
Intercept Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -69.43 | -19.68 | -4.73 | -6.27 | 0.69 | -13.64 | -6.99 | -3.31 | -32.44 | -14.93 | -4.73 |
PEG Ratio | 1.33 | 0.25 | -0.11 | 0.06 | -0.00 | 0.24 | 0.13 | -0.00 | 0.49 | 0.20 | 0.21 |
PS Ratio | 8.73 | 5.51 | 8.23 | 6.62 | 6.16 | 5.72 | 5.45 | 5.19 | 5.08 | 6.86 | 9.37 |
PB Ratio | 10.78 | 6.83 | 8.33 | 5.49 | 4.44 | -1.11 | -1.3 | -2.61 | -3.02 | -3.26 | -3.82 |
P/FCF Ratio | 46.47 | -19.72 | -10.85 | -113.37 | -28.23 | 28.90 | -24 | 124.58 | 101.59 | 147.27 | -13.9 |
P/OCF Ratio | 46.44 | -19.81 | -10.85 | -106.36 | -28.79 | 27.87 | -24.01 | 124.58 | 101.59 | 146.62 | -14 |
OCF/S Ratio | 0.19 | -0.28 | -0.76 | -0.06 | -0.21 | 0.21 | -0.23 | 0.04 | 0.05 | 0.05 | -0.67 |
Debt / Equity Ratio | 3.12 | 4.94 | 4.96 | 3.57 | 3.09 | -1.93 | -1.95 | -2.97 | -3.46 | -2.89 | -2.91 |
Quick Ratio | 4.19 | 2.48 | 2.34 | 2.35 | 2.43 | 2.97 | 3.09 | 3.01 | 3.39 | 3.34 | 3.28 |
Current Ratio | 4.22 | 2.52 | 2.37 | 2.35 | 2.46 | 3.22 | 3.16 | 3.01 | 3.45 | 3.39 | 3.33 |
Asset Turnover | 0.23 | 0.17 | 0.13 | 0.14 | 0.14 | 0.14 | 0.18 | 0.18 | 0.18 | 0.18 | 0.16 |
Interest Coverage | -2.98 | -2.53 | -11.26 | -6.74 | -2.21 | -2.28 | -1.54 | -1.36 | -0.46 | 0.06 | -2.36 |
Return on Equity | -0.04 | -0.09 | -0.44 | -0.22 | 1.61 | 0.02 | 0.05 | 0.20 | 0.02 | 0.05 | 0.20 |
Return on Assets | -0.01 | -0.01 | -0.06 | -0.04 | 0.31 | -0.02 | -0.03 | -0.07 | -0.01 | -0.02 | -0.08 |
Return on Invested Capital | -0.04 | -0.03 | -0.07 | -0.05 | 0.04 | -0.02 | -0.03 | -0.08 | -0.02 | n/a | -0.08 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 1.00 | 1.00 | 1.00 | 1.00 | 0.99 | 1.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
Net Profit Margin | -0.03 | -0.07 | -0.44 | -0.26 | 2.24 | -0.1 | -0.2 | -0.39 | -0.04 | -0.11 | -0.49 |
Pretax Profit Margin | -0.03 | -0.07 | -0.47 | -0.23 | -1.34 | -0.28 | -0.2 | -0.39 | -0.04 | -0.11 | -0.49 |
Operating Profit Margin | -0.05 | -0.09 | -0.47 | -0.24 | -0.13 | -0.19 | -0.12 | -0.23 | -0.07 | 0.01 | -0.36 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | 0.06 | -0.04 | -0.43 | -0.19 | -0.1 | -0.2 | -0.12 | -0.23 | -0.06 | 0.01 | -0.33 |